Cristina Colarossi Selected Research

Cristina Colarossi Research Topics

Disease

25	Neoplasms (Cancer) 03/2022 - 08/2007
4	Glioblastoma (Glioblastoma Multiforme) 02/2022 - 08/2007
3	Carcinoma (Carcinomatosis) 07/2021 - 01/2021
2	Lung Neoplasms (Lung Cancer) 07/2021 - 03/2021
2	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2008
2	Rectal Neoplasms (Rectal Cancer) 01/2021 - 12/2020
2	Endometriosis 01/2021 - 01/2021
2	Papillary Thyroid Cancer 05/2017 - 01/2016
2	Melanoma (Melanoma, Malignant) 12/2013 - 08/2007
1	Splenic Rupture 05/2022
1	Pancytopenia 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2022
1	Adenocarcinoma 03/2022
1	Diarrhea 03/2022
1	Exanthema (Rash) 03/2022
1	Paronychia 03/2022
1	Medullary Carcinoma 09/2021
1	Inflammation (Inflammations) 09/2021
1	Mouth Neoplasms (Oral Cancer) 07/2021
1	Glioma (Gliomas) 04/2021
1	Leiomyomatosis 01/2021
1	Cicatrix (Scar) 01/2021
1	Astrocytoma (Pilocytic Astrocytoma) 12/2020
1	Brain Neoplasms (Brain Tumor) 12/2020
1	Infections 11/2016
1	Stomach Neoplasms (Stomach Cancer) 12/2014
1	Testicular Neoplasms (Testicular Cancer) 10/2014
1	Colorectal Neoplasms (Colorectal Cancer) 09/2014
1	Microscopic Colitis 05/2011
1	Breast Neoplasms (Breast Cancer) 01/2011
1	Multiple Myeloma 01/2011
1	Ductal Carcinoma 01/2011
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 09/2010
1	Fibrosis (Cirrhosis) 01/2008

Drug/Important Bio-Agent (IBA)

4	MicroRNAs (MicroRNA)IBA 07/2021 - 05/2017
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2008
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2021
2	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 12/2014
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2021 - 09/2007
2	CytokinesIBA 04/2021 - 12/2006
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2011
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 10/2011
2	AntigensIBA 10/2014 - 01/2011
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2008 - 08/2005
1	LenograstimIBA 05/2022
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2022
1	AfatinibIBA 03/2022
1	Tyrosine Kinase InhibitorsIBA 03/2022
1	ErbB Receptors (EGF Receptor)IBA 03/2022
1	Oxygen (Dioxygen)IBA 02/2022
1	CalciumIBA 02/2022
1	1,2,4-trioxaneIBA 02/2022
1	OzoneIBA 02/2022
1	OilsIBA 02/2022
1	Biological ProductsIBA 09/2021
1	BX795IBA 09/2021
1	Complement Factor B (Factor B)IBA 09/2021
1	RadonIBA 07/2021
1	DNA AdductsIBA 07/2021
1	Environmental CarcinogensIBA 07/2021
1	SmokeIBA 07/2021
1	veliparibIBA 07/2021
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 04/2021
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2020
1	Tumor Biomarkers (Tumor Markers)IBA 05/2017
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2014
1	Docetaxel (Taxotere)FDA Link 12/2014
1	MC1568IBA 12/2014
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2013
1	Chromogranin AIBA 05/2012
1	SynaptophysinIBA 05/2012
1	Lansoprazole (Prevacid)FDA LinkGeneric 05/2011
1	Hormones (Hormone)IBA 01/2011
1	NF-kappa B (NF-kB)IBA 01/2011
1	Complement System Proteins (Complement)IBA 01/2011
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2011
1	AutoantigensIBA 09/2010
1	Talc FDA Link 09/2010
1	WT1 ProteinsIBA 09/2008
1	beta CateninIBA 09/2008
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2008
1	integrin beta6IBA 01/2008
1	Integrin alphaVIBA 01/2008

Therapy/Procedure

11	Therapeutics 03/2022 - 01/2008
3	Radiotherapy 01/2022 - 12/2020
2	Operative Surgical Procedures 01/2021 - 12/2020
2	Immunotherapy 10/2014 - 01/2011
1	Aftercare (After-Treatment) 05/2022
1	Stem Cell Transplantation 05/2022
1	Splenectomy 05/2022
1	Drug Tapering 03/2022
1	Uterine Myomectomy 01/2021
1	Cesarean Section (Caesarean Section) 01/2021
1	Drug Therapy (Chemotherapy) 12/2020
1	Adjuvant Radiotherapy 12/2020
1	Bone Transplantation (Bone Grafting) 11/2016
1	Lasers (Laser) 12/2014
1	Pleurodesis 09/2010